Pricing Log in Create free account

Cullinan Therapeutics, Inc. (CGEM) vs DBV Technologies S.A. (DBVT)

Cullinan Therapeutics, Inc. and DBV Technologies S.A. are both Biotechnology companies. Cullinan Therapeutics, Inc. and DBV Technologies S.A. are of similar size ($746.5M and $730.4M). Cullinan Therapeutics, Inc. has the higher net margin (0.00% vs −5,547.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cullinan Therapeutics, Inc. leads on 8 and DBV Technologies S.A. on 4.

Valuation

Metric CGEM DBVT Biotechnology median
P/E n/m n/m 11.58
P/S n/m 286.84 9.61
P/B 2.16 7.21 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m 242.54 9.43
Earnings yield (27.39%) (26.00%) (32.28%)
Free cash flow yield (22.88%) (17.89%) (22.27%)

Profitability

Metric CGEM DBVT Biotechnology median
Gross margin — 100.00% 68.81%
Operating margin 0.00% (5,571.63%) 0.00%
Net margin 0.00% (5,547.30%) 0.00%
Free cash flow margin 0.00% (5,131.50%) 0.00%
Return on equity (50.30%) (205.75%) (50.30%)
Return on assets (46.30%) (127.19%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGEM DBVT Biotechnology median
Revenue growth (TTM) — (33.42%) 6.78%
EPS growth (last fiscal year) (20.86%) 10.26% 29.88%
Revenue growth, 5-year CAGR — (12.95%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEM DBVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.42 3.24 4.74
Net debt to EBITDA 1.57 1.35 1.01

Dividend

Metric CGEM DBVT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CGEM DBVT Biotechnology median
Market cap 730.42m 746.54m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack